Maternity versus non-maternity healthcare settings for the diagnosis of gestational diabetes or diabetes in pregnancy.

Cochrane Database Syst RevOct 29, 2026 (epub)

Nora Cryns, Julia Schroer, Anna H Noel-Storr et al.

✦ AI-curated · Sources linked

In 30 seconds

This Cochrane systematic review and meta-analysis assessed whether maternity or non-maternity healthcare settings affect screening and diagnosis of gestational diabetes or diabetes in pregnancy. It found one randomised trial involving 781 pregnant participants, evaluating screening for gestational diabetes only. Screening in a maternity setting may improve compliance with screening and follow-up guidelines compared with a non-maternity setting (risk ratio 1.69, 95% confidence interval 1.53 to 1.87; 781 participants). The review found no eligible non-randomised studies, and evidence for other outcomes was limited or uncertain.

Key findings

  • Maternity-setting screening may increase compliance with screening and follow-up guidelines (risk ratio 1.69, 95% confidence interval 1.53 to 1.87; 781 participants; low-certainty evidence).
  • Time to access antenatal diabetes care may be shorter in maternity settings (mean difference -4.70 days, 95% confidence interval -6.03 to -3.37; 690 participants; low-certainty evidence).
  • Only one trial was included; it evaluated gestational diabetes screening and did not identify ongoing studies or studies awaiting classification.

Why it matters

The findings suggest that the setting in which screening is delivered may influence whether pregnant people complete screening and follow-up, as well as access to antenatal diabetes care. These service outcomes matter for implementing screening pathways, but the evidence base is too limited to establish effects on maternal or child health outcomes or to determine whether the findings apply to diabetes in pregnancy more broadly.

What to keep in mind

Evidence came from one trial. For outcomes other than screening compliance, analyses used per-protocol rather than original randomised groups, creating substantial sample-size disparities and largely nullifying the protections of randomisation. Evidence certainty was low for the reported service outcomes.

Source

Published in Cochrane Database Syst Rev. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Obstetrics & Gynecology

Clinical ResearchOncology (Medical)

Curative-intent management of de novo metastatic nasopharyngeal carcinoma: an evidence-based consensus guideline from the International Collaborating Oncology Organisations.

This international consensus guideline addresses curative-intent management of de novo metastatic nasopharyngeal carcinoma, a population historically treated with palliative intent.

Lancet OncolOct 29, 2026Read summary
Clinical ResearchHematology

Decitabine plus busulfan-cyclophosphamide versus busulfan-cyclophosphamide myeloablative conditioning before allogeneic haematopoietic stem cell transplantation for reducing risk of relapse in adult KMT2A‑rearranged leukaemia in China: an open-label, multicentre, randomised phase 3 trial.

This open-label, multicentre, randomised phase 3 trial compared decitabine plus busulfan-cyclophosphamide (DAC-BuCy) with BuCy conditioning before allogeneic HSCT in 130 patients aged 14–65 years with KMT2A-rearranged…

Lancet HaematolOct 30, 2026Read summary
Clinical ResearchPediatrics

Prone positioning and high-frequency oscillatory ventilation in early paediatric acute respiratory distress syndrome (PROSpect): an international, two-by-two factorial, response-adaptive, phase 3, randomised controlled trial.

PROSpect was an international, two-by-two factorial, phase 3 randomised controlled trial comparing prone with supine positioning and high-frequency oscillatory ventilation (HFOV) with conventional mechanical ventilation…

LancetOct 30, 2026Read summary

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.